TITLE

Exenatide + rosiglitazone added to metformin

PUB. DATE
July 2010
SOURCE
Internal Medicine Alert;7/29/2010 Supplement, p112
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that initial therapy for type 2 diabetes (DM2) should be mixed with metformin with the add-on therapy of exenatide (EXE) and rosiglitazone (ROS) which are effective therapies for glucose control.
ACCESSION #
53269511

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics